Author

Y. Ghotmi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Bhaskara· 1 shared A. Koshy· 1 shared B. Pentelute· 1 shared C. Fadzen· 1 shared C. Farquhar· 1 shared C.-F. Cho· 1 shared E. A. Chiocca· 1 shared E. Murrell· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Bhaskara

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BTP-7, a novel peptide for therapeutic targeting of malignant brain tumors

N. von Spreckelsen, Y. Ghotmi, C. Fadzen, J. Wolfe, C. Farquhar, N. Hartrampf, S. Bergmann, M. Zdioruk, J. R. Wasserburg, E. Murrell, F. Bononi, L. Luyt, M. Lamfers, K. Ligon, E. A. Chiocca, , C.-F. Cho

This study identifies BTP-7, a peptide that targets dg-Bcan in glioma cells, enhancing drug delivery and survival in tumor-bearing mice.

bioRxiv · May 21, 2020 · PreprintBioengineering

The ROP16III-dependent early immune response determines the sub-acute CNS immune response and type III Toxoplasma gondii survival

S. Tuladhar, A. Koshy, J. A. Kochanowsky, A. Bhaskara, Y. Ghotmi

This study shows that the type III Toxoplasma gondii strain uses ROP16III to modulate early immune responses, which influences sub-acute CNS immune responses and parasite survival.

bioRxiv · May 21, 2019Microbiology